pH‐Responsive, Self‐Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death

Author:

Lu Yu12ORCID,Zhu Di12,Hu Bo12,Chen Rong12,Wang Xin12,Xu Xiaoxue3,Wang Wenjing4,Wu Hao5,Wang Yuji12ORCID

Affiliation:

1. Department of Medicinal Chemistry College of Pharmaceutical Sciences of Capital Medical University Beijing 100069 P. R. China

2. Beijing Area Major Laboratory of Peptide and Small Molecular Drugs Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China Beijing Laboratory of Biomedical Materials Laboratory for Clinical Medicine Capital Medical University Beijing 100069 P. R. China

3. Department of Core Facility Center Capital Medical University Beijing 100069 P. R. China

4. Beijing Institute of Hepatology Beijing Youan Hospital Capital Medical University Beijing 100069 P. R. China

5. Xuanwu Hospital Capital Medical University Beijing 100053 P. R. China

Abstract

AbstractSeveral DNA‐damaging antitumor agents, including ruthenium complexes, induce immunogenic cell death (ICD). In this study, an arginyl‐glycyl‐aspartic acid (RGD) peptide‐modified carboline ruthenium complex (KS‐Ru) is synthesized as a chemotherapeutic nanodrug and an ICD inducer. The RGD peptide, an integrin ligand, provides tumor‐specific targeting and promotes self‐assembly of the KS‐Ru complex. The pH‐responsive self‐assembly is assessed through transmission and scanning electron microscopy. Additionally, in vitro cytotoxic activity and anti‐metastasis ability are evaluated using MTT and Transwell assays, respectively, along with cellular immunofluorescence staining and imaging flow cytometry. The ability of the complex to inhibit primary tumor formation and lung metastasis in vivo is evaluated using Lewis lung cancer and A549 xenograft models. Furthermore, the tumor immune microenvironment is evaluated using single‐cell flow mass cytometry. KS‐Ru translocates to the nucleus, causing DNA damage and inducing ICD. Within the lysosomes, KS‐Ru self‐assembled into nanoflowers, leading to lysosomal swelling and apoptosis. Notably, the as‐synthesized pH‐dependent ruthenium nanomedicine achieves dual functionality—chemotherapy and immunotherapy. Moreover, the pH‐responsive self‐assembly of KS‐Ru enables simultaneous mechanisms in the lysosome and nucleus, thereby lowering the likelihood of drug resistance. This study provides valuable insight for the design of novel ruthenium‐based nanoantitumor drugs.

Funder

Beijing Municipal Commission of Education

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3